Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C16H20N2O5.Tc |
| Molecular Weight | 739.5871 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[99Tc+4].CCCCC1=CC=C(NC(=O)CN(CC([O-])=O)CC([O-])=O)C=C1.CCCCC2=CC=C(NC(=O)CN(CC([O-])=O)CC([O-])=O)C=C2
InChI
InChIKey=NWCXFSATWNRRSR-FCHARDOESA-J
InChI=1S/2C16H22N2O5.Tc/c2*1-2-3-4-12-5-7-13(8-6-12)17-14(19)9-18(10-15(20)21)11-16(22)23;/h2*5-8H,2-4,9-11H2,1H3,(H,17,19)(H,20,21)(H,22,23);/q;;+4/p-4/i;;1+1
| Molecular Formula | Tc |
| Molecular Weight | 98.9063 |
| Charge | 4 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C16H20N2O5 |
| Molecular Weight | 320.3404 |
| Charge | -2 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionCurator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Curator's Comment: description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/books/NBK215133/ | https://www.iaea.org/OurWork/ST/NE/NEFW/Technical-Areas/RRS/documents /mo99/WORKINGMATERIALSmo99CM.pdf | https://www.ncbi.nlm.nih.gov/pubmed/27854401
Molybdenum-99 (99Mo, half-life = 66 h) is a parent radionuclide of a diagnostic nuclear isotope. It decays in technetium-99 m (half-life = 6 h), which is used in over 30 million procedures per year around the world. Between 95 and 98 percent of Mo-99 is currently being produced using highly enriched uranium (HEU) targets. Other medical isotopes such as iodine-131 (I-131) and xenon-133 (Xe-133) are by-products of the Mo-99 production process and will be sufficiently available if Mo-99 is available.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Diagnostic | OSTEOLITE Approved UseUnknown Launch Date2.50992001E11 |
|||
| Diagnostic | DRAXIMAGE MDP-10 Approved UseMDP-25 (Kit for the Preparation of Technetium Tc 99m Medronate) may be used as a bone imaging agent to delineate areas of altered osteogenesis. Launch Date2.80972788E11 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:01:20 UTC 2023
by
admin
on
Fri Dec 15 15:01:20 UTC 2023
|
| Record UNII |
0J544483OZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
0J544483OZ
Created by
admin on Fri Dec 15 15:01:20 UTC 2023 , Edited by admin on Fri Dec 15 15:01:20 UTC 2023
|
PRIMARY | |||
|
SUB15463MIG
Created by
admin on Fri Dec 15 15:01:20 UTC 2023 , Edited by admin on Fri Dec 15 15:01:20 UTC 2023
|
PRIMARY | |||
|
91800131
Created by
admin on Fri Dec 15 15:01:20 UTC 2023 , Edited by admin on Fri Dec 15 15:01:20 UTC 2023
|
PRIMARY | |||
|
100000092311
Created by
admin on Fri Dec 15 15:01:20 UTC 2023 , Edited by admin on Fri Dec 15 15:01:20 UTC 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |